Related Experiment Video
Updated: Nov 18, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer
Hiroki Sekine1, Hozumi Motohashi1
1Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.
Abstract:
Cancer cells exhibit unique metabolic features and take advantage of them to enhance their survival and proliferation. While the activation of NRF2 (nuclear factor erythroid 2-like 2; NFE2L2), a CNC (cap'n'collar) family transcription factor, is effective for the prevention and alleviation of various diseases, NRF2 contributes to cancer malignancy by promoting aggressive tumorigenesis and conferring therapeutic resistance. NRF2-mediated metabolic reprogramming and increased antioxidant capacity underlie the malignant behaviors of NRF2-activated cancer cells. Another member of the CNC family, NRF1, plays a key role in the therapeutic resistance of cancers. Since NRF1 maintains proteasome activity by inducing proteasome subunit genes in response to proteasome inhibitors, NRF1 protects cancer cells from proteotoxicity induced by anticancer proteasome inhibitors. An important metabolite that activates NRF1 is UDP-GlcNAc (uridine diphosphate N-acetylglucosamine), which is abundantly generated in many cancer cells from glucose and glutamine via the hexosamine pathway. Thus, the metabolic signatures of cancer cells are closely related to the oncogenic and tumor-promoting functions of CNC family members. In this review, we provide a brief overview of NRF2-mediated cancer malignancy and elaborate on NRF1-mediated drug resistance affected by an oncometabolite UDP-GlcNAc.
Insights
Cancer cells exploit metabolism for survival. Transcription factors NRF2 and NRF1 promote cancer malignancy and drug resistance, respectively, through metabolic reprogramming and proteasome activity regulation.
Area of Science:
- Cellular metabolism
- Cancer biology
- Molecular oncology
Background:
- Cancer cells utilize unique metabolic pathways for survival and proliferation.
- Nuclear factor erythroid 2-like 2 (NRF2) activation promotes cancer malignancy and therapeutic resistance via metabolic reprogramming.
- Nuclear factor erythroid 1 (NRF1) contributes to cancer drug resistance by maintaining proteasome activity.
Purpose of the Study:
- To review NRF2-mediated cancer malignancy.
- To elaborate on NRF1-mediated drug resistance influenced by UDP-GlcNAc.
Main Methods:
- Literature review focusing on NRF2 and NRF1 functions in cancer.
- Analysis of metabolic reprogramming in cancer cells.
- Examination of the role of UDP-GlcNAc in NRF1 activation.
Main Results:
- NRF2 activation enhances cancer cell tumorigenesis and resistance.
- NRF1 protects cancer cells from proteasome inhibitor toxicity.
- UDP-GlcNAc, generated via the hexosamine pathway, activates NRF1.
Conclusions:
- Cancer cell metabolic signatures are linked to CNC family member functions.
- NRF2 and NRF1 play critical roles in cancer progression and therapeutic resistance.
- Targeting NRF1 and UDP-GlcNAc metabolism may offer strategies for overcoming cancer drug resistance.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
Master Transcription Regulators
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...